Cargando…

The Epithelial to Mesenchymal Transition Promotes Glutamine Independence by Suppressing GLS2 Expression

Identifying bioenergetics that facilitate the epithelial to mesenchymal transition (EMT) in breast cancer cells may uncover targets to treat incurable metastatic disease. Metastasis is the number one cause of cancer-related deaths; therefore, it is urgent to identify new treatment strategies to prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramirez-Peña, Esmeralda, Arnold, James, Shivakumar, Vinita, Joseph, Robiya, Vidhya Vijay, Geraldine, den Hollander, Petra, Bhangre, Neeraja, Allegakoen, Paul, Prasad, Rishika, Conley, Zachary, Matés, José M., Márquez, Javier, Chang, Jeffrey T., Vasaikar, Suhas, Soundararajan, Rama, Sreekumar, Arun, Mani, Sendurai A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826439/ https://www.ncbi.nlm.nih.gov/pubmed/31652551 http://dx.doi.org/10.3390/cancers11101610

Ejemplares similares

EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures
por: Vasaikar, Suhas V., et al.
Publicado: (2020)

The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition
por: Taube, Joseph H., et al.
Publicado: (2017)

Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing
por: Deshmukh, Abhijeet P., et al.
Publicado: (2021)

Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells
por: Szeliga, Monika, et al.
Publicado: (2013)

GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
por: Vijay, Geraldine Vidhya, et al.
Publicado: (2019)

Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer
por: Saha, Subbroto Kumar, et al.
Publicado: (2019)

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis
por: Xu, Kangdi, et al.
Publicado: (2022)

Mammalian Glutaminase Gls2 Gene Encodes Two Functional Alternative Transcripts by a Surrogate Promoter Usage Mechanism
por: Martín-Rufián, Mercedes, et al.
Publicado: (2012)

FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition
por: Pietilä, Mika, et al.
Publicado: (2016)

Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism
por: Chen, Ping, et al.
Publicado: (2021)

GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
por: Mukha, Anna, et al.
Publicado: (2021)

A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome
por: Soundararajan, Rama, et al.
Publicado: (2015)

CD8(+) T cells inhibit metastasis and CXCL4 regulates its function
por: Joseph, Robiya, et al.
Publicado: (2021)

Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer
por: Balcik-Ercin, Pelin, et al.
Publicado: (2021)

Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition
por: Galicia-Vázquez, Gabriela, et al.
Publicado: (2018)

Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge
por: Bushnell, Grace G., et al.
Publicado: (2021)

Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation
por: López de la Oliva, Amada R., et al.
Publicado: (2020)

UDP-Glucose 6-Dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression
por: Arnold, James M., et al.
Publicado: (2019)

Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers
por: Soundararajan, Rama, et al.
Publicado: (2018)

GLS2 shapes ferroptosis in hepatocellular carcinoma
por: Suzuki, Sawako, et al.
Publicado: (2023)

Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR-330-3p/GLS axis
por: Qian, Cuijuan, et al.
Publicado: (2021)

Author Correction: Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation
por: López de la Oliva, Amada R., et al.
Publicado: (2021)

Single-Cell Cloning of Breast Cancer Cells Secreting Specific Subsets of Extracellular Vesicles
por: Fathi, Mohsen, et al.
Publicado: (2021)

Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis
por: Chattopadhyaya, Sikta, et al.
Publicado: (2022)

Selenite inhibits glutamine metabolism and induces apoptosis by regulating GLS1 protein degradation via APC/C-CDH1 pathway in colorectal cancer cells
por: Zhao, Junzhang, et al.
Publicado: (2016)

m5C-methylated lncRNA NR_033928 promotes gastric cancer proliferation by stabilizing GLS mRNA to promote glutamine metabolism reprogramming
por: Fang, Lang, et al.
Publicado: (2023)

Role of p38 MAP kinase in cancer stem cells and metastasis
por: Kudaravalli, Sriya, et al.
Publicado: (2022)

Forkhead Box Transcription Factors: Double-Edged Swords in Cancer
por: Castaneda, Maria, et al.
Publicado: (2022)

Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer
por: Zhang, Junfeng, et al.
Publicado: (2019)

Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
por: Ren, L., et al.
Publicado: (2020)

Structure and activation mechanism of the human liver-type glutaminase GLS2
por: Ferreira, Igor M., et al.
Publicado: (2021)

RandomForestsGLS: An R package for Random Forests for dependent data
por: Saha, Arkajyoti, et al.
Publicado: (2022)

EMT-induced metabolite signature identifies poor clinical outcome
por: Bhowmik, Salil Kumar, et al.
Publicado: (2015)

Comparison of GLS via echocardiography and tissue tracking by Cardiac Magnetic Resonance imaging
por: Tantiongco, John-Paul, et al.
Publicado: (2015)

GLS loss of function causes autosomal recessive spastic ataxia and optic atrophy
por: Lynch, David S., et al.
Publicado: (2018)

Complicated Staphylococcus aureus Bacteremia (SAB) Is Associated with Genetic Variation in GLS2
por: Fowler, Vance, et al.
Publicado: (2017)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
por: Winarno, G. N. A., et al.
Publicado: (2020)

Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction
por: Liu, Zheng, et al.
Publicado: (2022)

GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights
por: Zhang, Danfeng, et al.
Publicado: (2023)

Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?
por: Visal, Tanvi H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n5btkhsgl408k0ia8amdqeo1ki